Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Attenuated Vaccines Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Bn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Bn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Attenuated Vaccines Market Analysis 2017-2021 and Forecast 2022-2032, By Vaccine Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Bn) Analysis By Vaccine Type, 2017-2021
5.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Vaccine Type, 2022-2032
5.3.1. Monovalent Vaccines
5.3.2. Multivalent Vaccines
5.4. Y-o-Y Growth Trend Analysis By Vaccine Type, 2017-2021
5.5. Absolute $ Opportunity Analysis By Vaccine Type, 2022-2032
6. Global Attenuated Vaccines Market Analysis 2017-2021 and Forecast 2022-2032, By Indication
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Bn) Analysis By Indication, 2017-2021
6.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Indication, 2022-2032
6.3.1. Influenza
6.3.2. Measles, Mumps & Rubella (MMR)
6.3.3. Polio
6.3.4. Chickenpox
6.3.5. Shingles
6.3.6. Rotavirus
6.3.7. Other Indications
6.4. Y-o-Y Growth Trend Analysis By Indication, 2017-2021
6.5. Absolute $ Opportunity Analysis By Indication, 2022-2032
7. Global Attenuated Vaccines Market Analysis 2017-2021 and Forecast 2022-2032, By Route of Administration
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Bn) Analysis By Route of Administration, 2017-2021
7.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Route of Administration, 2022-2032
7.3.1. Intramuscular
7.3.2. Subcutaneous
7.3.3. Oral
7.3.4. Intranasal
7.3.5. Intravenous
7.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2017-2021
7.5. Absolute $ Opportunity Analysis By Route of Administration, 2022-2032
8. Global Attenuated Vaccines Market Analysis 2017-2021 and Forecast 2022-2032, By Age Group
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Bn) Analysis By Age Group, 2017-2021
8.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Age Group, 2022-2032
8.3.1. Pediatric
8.3.2. Adolcents
8.3.3. Adults
8.3.4. Geriatric
8.4. Y-o-Y Growth Trend Analysis By Age Group, 2017-2021
8.5. Absolute $ Opportunity Analysis By Age Group, 2022-2032
9. Global Attenuated Vaccines Market Analysis 2017-2021 and Forecast 2022-2032, By End User
9.1. Introduction / Key Findings
9.2. Historical Market Size Value (US$ Bn) Analysis By End User, 2017-2021
9.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By End User, 2022-2032
9.3.1. Hospitals
9.3.2. Clinics
9.3.3. Others
9.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
9.5. Absolute $ Opportunity Analysis By End User, 2022-2032
10. Global Attenuated Vaccines Market Analysis 2017-2021 and Forecast 2022-2032, By Region
10.1. Introduction
10.2. Historical Market Size Value (US$ Bn) Analysis By Region, 2017-2021
10.3. Current Market Size Value (US$ Bn) Analysis and Forecast By Region, 2022-2032
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. East Asia
10.3.5. South Asia
10.3.6. Oceania
10.3.7. MEA
10.4. Market Attractiveness Analysis By Region
11. North America Attenuated Vaccines Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Value (US$ Bn)ed States
11.2.1.2. Canada
11.2.2. By Vaccine Type
11.2.3. By Indication
11.2.4. By Route of Administration
11.2.5. By Age Group
11.2.6. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Vaccine Type
11.3.3. By Indication
11.3.4. By Route of Administration
11.3.5. By Age Group
11.3.6. By End User
11.4. Key Takeaways
12. Latin America Attenuated Vaccines Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. Brazil
12.2.1.2. Mexico
12.2.1.3. Rest of Latin America
12.2.2. By Vaccine Type
12.2.3. By Indication
12.2.4. By Route of Administration
12.2.5. By Age Group
12.2.6. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Vaccine Type
12.3.3. By Indication
12.3.4. By Route of Administration
12.3.5. By Age Group
12.3.6. By End User
12.4. Key Takeaways
13. Europe Attenuated Vaccines Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. Germany
13.2.1.2. U.K.
13.2.1.3. France
13.2.1.4. Spain
13.2.1.5. Italy
13.2.1.6. Rest of Europe
13.2.2. By Vaccine Type
13.2.3. By Indication
13.2.4. By Route of Administration
13.2.5. By Age Group
13.2.6. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Vaccine Type
13.3.3. By Indication
13.3.4. By Route of Administration
13.3.5. By Age Group
13.3.6. By End User
13.4. Key Takeaways
14. East Asia Attenuated Vaccines Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Vaccine Type
14.2.3. By Indication
14.2.4. By Route of Administration
14.2.5. By Age Group
14.2.6. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Vaccine Type
14.3.3. By Indication
14.3.4. By Route of Administration
14.3.5. By Age Group
14.3.6. By End User
14.4. Key Takeaways
15. South Asia Attenuated Vaccines Market Analysis 2017-2021 and Forecast 2022-2032, By Country
15.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
15.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032
15.2.1. By Country
15.2.1.1. India
15.2.1.2. ASEAN
15.2.1.3. Rest of South Asia
15.2.2. By Vaccine Type
15.2.3. By Indication
15.2.4. By Route of Administration
15.2.5. By Age Group
15.2.6. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Vaccine Type
15.3.3. By Indication
15.3.4. By Route of Administration
15.3.5. By Age Group
15.3.6. By End User
15.4. Key Takeaways
16. Oceania Attenuated Vaccines Market Analysis 2017-2021 and Forecast 2022-2032, By Country
16.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
16.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032
16.2.1. By Country
16.2.1.1. Australia
16.2.1.2. New Zealand
16.2.2. By Vaccine Type
16.2.3. By Indication
16.2.4. By Route of Administration
16.2.5. By Age Group
16.2.6. By End User
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Vaccine Type
16.3.3. By Indication
16.3.4. By Route of Administration
16.3.5. By Age Group
16.3.6. By End User
16.4. Key Takeaways
17. MEA Attenuated Vaccines Market Analysis 2017-2021 and Forecast 2022-2032, By Country
17.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
17.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032
17.2.1. By Country
17.2.1.1. GCC Countries
17.2.1.2. South Africa
17.2.1.3. Israel
17.2.1.4. Rest of MEA
17.2.2. By Vaccine Type
17.2.3. By Indication
17.2.4. By Route of Administration
17.2.5. By Age Group
17.2.6. By End User
17.3. Market Attractiveness Analysis
17.3.1. By Country
17.3.2. By Vaccine Type
17.3.3. By Indication
17.3.4. By Route of Administration
17.3.5. By Age Group
17.3.6. By End User
17.4. Key Takeaways
18. Key Countries Attenuated Vaccines Market Analysis
18.1. Value (US$ Bn)ed States
18.1.1. Pricing Analysis
18.1.2. Market Share Analysis, 2021
18.1.2.1. By Vaccine Type
18.1.2.2. By Indication
18.1.2.3. By Route of Administration
18.1.2.4. By Age Group
18.1.2.5. By End User
18.2. Canada
18.2.1. Pricing Analysis
18.2.2. Market Share Analysis, 2021
18.2.2.1. By Vaccine Type
18.2.2.2. By Indication
18.2.2.3. By Route of Administration
18.2.2.4. By Age Group
18.2.2.5. By End User
18.3. Brazil
18.3.1. Pricing Analysis
18.3.2. Market Share Analysis, 2021
18.3.2.1. By Vaccine Type
18.3.2.2. By Indication
18.3.2.3. By Route of Administration
18.3.2.4. By Age Group
18.3.2.5. By End User
18.4. Mexico
18.4.1. Pricing Analysis
18.4.2. Market Share Analysis, 2021
18.4.2.1. By Vaccine Type
18.4.2.2. By Indication
18.4.2.3. By Route of Administration
18.4.2.4. By Age Group
18.4.2.5. By End User
18.5. Rest of Latin America
18.5.1. Pricing Analysis
18.5.2. Market Share Analysis, 2021
18.5.2.1. By Vaccine Type
18.5.2.2. By Indication
18.5.2.3. By Route of Administration
18.5.2.4. By Age Group
18.5.2.5. By End User
18.6. Germany
18.6.1. Pricing Analysis
18.6.2. Market Share Analysis, 2021
18.6.2.1. By Vaccine Type
18.6.2.2. By Indication
18.6.2.3. By Route of Administration
18.6.2.4. By Age Group
18.6.2.5. By End User
18.7. U.K.
18.7.1. Pricing Analysis
18.7.2. Market Share Analysis, 2021
18.7.2.1. By Vaccine Type
18.7.2.2. By Indication
18.7.2.3. By Route of Administration
18.7.2.4. By Age Group
18.7.2.5. By End User
18.8. France
18.8.1. Pricing Analysis
18.8.2. Market Share Analysis, 2021
18.8.2.1. By Vaccine Type
18.8.2.2. By Indication
18.8.2.3. By Route of Administration
18.8.2.4. By Age Group
18.8.2.5. By End User
18.9. Spain
18.9.1. Pricing Analysis
18.9.2. Market Share Analysis, 2021
18.9.2.1. By Vaccine Type
18.9.2.2. By Indication
18.9.2.3. By Route of Administration
18.9.2.4. By Age Group
18.9.2.5. By End User
18.10. Italy
18.10.1. Pricing Analysis
18.10.2. Market Share Analysis, 2021
18.10.2.1. By Vaccine Type
18.10.2.2. By Indication
18.10.2.3. By Route of Administration
18.10.2.4. By Age Group
18.10.2.5. By End User
18.11. Rest of Europe
18.11.1. Pricing Analysis
18.11.2. Market Share Analysis, 2021
18.11.2.1. By Vaccine Type
18.11.2.2. By Indication
18.11.2.3. By Route of Administration
18.11.2.4. By Age Group
18.11.2.5. By End User
18.12. China
18.12.1. Pricing Analysis
18.12.2. Market Share Analysis, 2021
18.12.2.1. By Vaccine Type
18.12.2.2. By Indication
18.12.2.3. By Route of Administration
18.12.2.4. By Age Group
18.12.2.5. By End User
18.13. Japan
18.13.1. Pricing Analysis
18.13.2. Market Share Analysis, 2021
18.13.2.1. By Vaccine Type
18.13.2.2. By Indication
18.13.2.3. By Route of Administration
18.13.2.4. By Age Group
18.13.2.5. By End User
18.14. South Korea
18.14.1. Pricing Analysis
18.14.2. Market Share Analysis, 2021
18.14.2.1. By Vaccine Type
18.14.2.2. By Indication
18.14.2.3. By Route of Administration
18.14.2.4. By Age Group
18.14.2.5. By End User
18.15. India
18.15.1. Pricing Analysis
18.15.2. Market Share Analysis, 2021
18.15.2.1. By Vaccine Type
18.15.2.2. By Indication
18.15.2.3. By Route of Administration
18.15.2.4. By Age Group
18.15.2.5. By End User
18.16. ASEAN
18.16.1. Pricing Analysis
18.16.2. Market Share Analysis, 2021
18.16.2.1. By Vaccine Type
18.16.2.2. By Indication
18.16.2.3. By Route of Administration
18.16.2.4. By Age Group
18.16.2.5. By End User
18.17. Rest of South Asia
18.17.1. Pricing Analysis
18.17.2. Market Share Analysis, 2021
18.17.2.1. By Vaccine Type
18.17.2.2. By Indication
18.17.2.3. By Route of Administration
18.17.2.4. By Age Group
18.17.2.5. By End User
18.18. Australia
18.18.1. Pricing Analysis
18.18.2. Market Share Analysis, 2021
18.18.2.1. By Vaccine Type
18.18.2.2. By Indication
18.18.2.3. By Route of Administration
18.18.2.4. By Age Group
18.18.2.5. By End User
18.19. New Zealand
18.19.1. Pricing Analysis
18.19.2. Market Share Analysis, 2021
18.19.2.1. By Vaccine Type
18.19.2.2. By Indication
18.19.2.3. By Route of Administration
18.19.2.4. By Age Group
18.19.2.5. By End User
18.20. GCC Countries
18.20.1. Pricing Analysis
18.20.2. Market Share Analysis, 2021
18.20.2.1. By Vaccine Type
18.20.2.2. By Indication
18.20.2.3. By Route of Administration
18.20.2.4. By Age Group
18.20.2.5. By End User
18.21. South Africa
18.21.1. Pricing Analysis
18.21.2. Market Share Analysis, 2021
18.21.2.1. By Vaccine Type
18.21.2.2. By Indication
18.21.2.3. By Route of Administration
18.21.2.4. By Age Group
18.21.2.5. By End User
18.22. Israel
18.22.1. Pricing Analysis
18.22.2. Market Share Analysis, 2021
18.22.2.1. By Vaccine Type
18.22.2.2. By Indication
18.22.2.3. By Route of Administration
18.22.2.4. By Age Group
18.22.2.5. By End User
18.23. Rest of MEA
18.23.1. Pricing Analysis
18.23.2. Market Share Analysis, 2021
18.23.2.1. By Vaccine Type
18.23.2.2. By Indication
18.23.2.3. By Route of Administration
18.23.2.4. By Age Group
18.23.2.5. By End User
19. Market Structure Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Market Share Analysis of Top Players
19.3.1. By Regional
19.3.2. By Vaccine Type
19.3.3. By Indication
19.3.4. By Route of Administration
19.3.5. By Age Group
19.3.6. By End User
20. Competition Analysis
20.1. Competition Deep Dive
20.1.1. GlaxoSmithKline
20.1.1.1. Overview
20.1.1.2. Product Portfolio
20.1.1.3. Profitability by Market Segments
20.1.1.4. Sales Footprint
20.1.1.5. Strategy Overview
20.1.1.5.1. Marketing Strategy
20.1.2. Merck
20.1.2.1. Overview
20.1.2.2. Product Portfolio
20.1.2.3. Profitability by Market Segments
20.1.2.4. Sales Footprint
20.1.2.5. Strategy Overview
20.1.2.5.1. Marketing Strategy
20.1.3. Pfizer
20.1.3.1. Overview
20.1.3.2. Product Portfolio
20.1.3.3. Profitability by Market Segments
20.1.3.4. Sales Footprint
20.1.3.5. Strategy Overview
20.1.3.5.1. Marketing Strategy
20.1.4. Sanofi
20.1.4.1. Overview
20.1.4.2. Product Portfolio
20.1.4.3. Profitability by Market Segments
20.1.4.4. Sales Footprint
20.1.4.5. Strategy Overview
20.1.4.5.1. Marketing Strategy
20.1.5. Astellas Pharma
20.1.5.1. Overview
20.1.5.2. Product Portfolio
20.1.5.3. Profitability by Market Segments
20.1.5.4. Sales Footprint
20.1.5.5. Strategy Overview
20.1.5.5.1. Marketing Strategy
20.1.6. Johnson and Johnson
20.1.6.1. Overview
20.1.6.2. Product Portfolio
20.1.6.3. Profitability by Market Segments
20.1.6.4. Sales Footprint
20.1.6.5. Strategy Overview
20.1.6.5.1. Marketing Strategy
20.1.7. CSL
20.1.7.1. Overview
20.1.7.2. Product Portfolio
20.1.7.3. Profitability by Market Segments
20.1.7.4. Sales Footprint
20.1.7.5. Strategy Overview
20.1.7.5.1. Marketing Strategy
20.1.8. Serum Institute Of India
20.1.8.1. Overview
20.1.8.2. Product Portfolio
20.1.8.3. Profitability by Market Segments
20.1.8.4. Sales Footprint
20.1.8.5. Strategy Overview
20.1.8.5.1. Marketing Strategy
21. Assumptions & Acronyms Used
22. Research Methodology
List of Tables
Table 1: Global Attenuated Vaccines Market Value (US$ Bn) Forecast by Region, 2017-2032
Table 2: Global Attenuated Vaccines Market Value (US$ Bn) Forecast by Vaccine Type, 2017-2032
Table 3: Global Attenuated Vaccines Market Value (US$ Bn) Forecast by Indication, 2017-2032
Table 4: Global Attenuated Vaccines Market Value (US$ Bn) Forecast by Route of Administration, 2017-2032
Table 5: Global Attenuated Vaccines Market Value (US$ Bn) Forecast by Age Group, 2017-2032
Table 6: Global Attenuated Vaccines Market Value (US$ Bn) Forecast by End User, 2017-2032
Table 7: North America Attenuated Vaccines Market Value (US$ Bn) Forecast by Country, 2017-2032
Table 8: North America Attenuated Vaccines Market Value (US$ Bn) Forecast by Vaccine Type, 2017-2032
Table 9: North America Attenuated Vaccines Market Value (US$ Bn) Forecast by Indication, 2017-2032
Table 10: North America Attenuated Vaccines Market Value (US$ Bn) Forecast by Route of Administration, 2017-2032
Table 11: North America Attenuated Vaccines Market Value (US$ Bn) Forecast by Age Group, 2017-2032
Table 12: North America Attenuated Vaccines Market Value (US$ Bn) Forecast by End User, 2017-2032
Table 13: Latin America Attenuated Vaccines Market Value (US$ Bn) Forecast by Country, 2017-2032
Table 14: Latin America Attenuated Vaccines Market Value (US$ Bn) Forecast by Vaccine Type, 2017-2032
Table 15: Latin America Attenuated Vaccines Market Value (US$ Bn) Forecast by Indication, 2017-2032
Table 16: Latin America Attenuated Vaccines Market Value (US$ Bn) Forecast by Route of Administration, 2017-2032
Table 17: Latin America Attenuated Vaccines Market Value (US$ Bn) Forecast by Age Group, 2017-2032
Table 18: Latin America Attenuated Vaccines Market Value (US$ Bn) Forecast by End User, 2017-2032
Table 19: Europe Attenuated Vaccines Market Value (US$ Bn) Forecast by Country, 2017-2032
Table 20: Europe Attenuated Vaccines Market Value (US$ Bn) Forecast by Vaccine Type, 2017-2032
Table 21: Europe Attenuated Vaccines Market Value (US$ Bn) Forecast by Indication, 2017-2032
Table 22: Europe Attenuated Vaccines Market Value (US$ Bn) Forecast by Route of Administration, 2017-2032
Table 23: Europe Attenuated Vaccines Market Value (US$ Bn) Forecast by Age Group, 2017-2032
Table 24: Europe Attenuated Vaccines Market Value (US$ Bn) Forecast by End User, 2017-2032
Table 25: East Asia Attenuated Vaccines Market Value (US$ Bn) Forecast by Country, 2017-2032
Table 26: East Asia Attenuated Vaccines Market Value (US$ Bn) Forecast by Vaccine Type, 2017-2032
Table 27: East Asia Attenuated Vaccines Market Value (US$ Bn) Forecast by Indication, 2017-2032
Table 28: East Asia Attenuated Vaccines Market Value (US$ Bn) Forecast by Route of Administration, 2017-2032
Table 29: East Asia Attenuated Vaccines Market Value (US$ Bn) Forecast by Age Group, 2017-2032
Table 30: East Asia Attenuated Vaccines Market Value (US$ Bn) Forecast by End User, 2017-2032
Table 31: South Asia Attenuated Vaccines Market Value (US$ Bn) Forecast by Country, 2017-2032
Table 32: South Asia Attenuated Vaccines Market Value (US$ Bn) Forecast by Vaccine Type, 2017-2032
Table 33: South Asia Attenuated Vaccines Market Value (US$ Bn) Forecast by Indication, 2017-2032
Table 34: South Asia Attenuated Vaccines Market Value (US$ Bn) Forecast by Route of Administration, 2017-2032
Table 35: South Asia Attenuated Vaccines Market Value (US$ Bn) Forecast by Age Group, 2017-2032
Table 36: South Asia Attenuated Vaccines Market Value (US$ Bn) Forecast by End User, 2017-2032
Table 37: Oceania Attenuated Vaccines Market Value (US$ Bn) Forecast by Country, 2017-2032
Table 38: Oceania Attenuated Vaccines Market Value (US$ Bn) Forecast by Vaccine Type, 2017-2032
Table 39: Oceania Attenuated Vaccines Market Value (US$ Bn) Forecast by Indication, 2017-2032
Table 40: Oceania Attenuated Vaccines Market Value (US$ Bn) Forecast by Route of Administration, 2017-2032
Table 41: Oceania Attenuated Vaccines Market Value (US$ Bn) Forecast by Age Group, 2017-2032
Table 42: Oceania Attenuated Vaccines Market Value (US$ Bn) Forecast by End User, 2017-2032
Table 43: MEA Attenuated Vaccines Market Value (US$ Bn) Forecast by Country, 2017-2032
Table 44: MEA Attenuated Vaccines Market Value (US$ Bn) Forecast by Vaccine Type, 2017-2032
Table 45: MEA Attenuated Vaccines Market Value (US$ Bn) Forecast by Indication, 2017-2032
Table 46: MEA Attenuated Vaccines Market Value (US$ Bn) Forecast by Route of Administration, 2017-2032
Table 47: MEA Attenuated Vaccines Market Value (US$ Bn) Forecast by Age Group, 2017-2032
Table 48: MEA Attenuated Vaccines Market Value (US$ Bn) Forecast by End User, 2017-2032
List of Charts
Figure 1: Global Attenuated Vaccines Market Value (US$ Bn) by Vaccine Type, 2022-2032
Figure 2: Global Attenuated Vaccines Market Value (US$ Bn) by Indication, 2022-2032
Figure 3: Global Attenuated Vaccines Market Value (US$ Bn) by Route of Administration, 2022-2032
Figure 4: Global Attenuated Vaccines Market Value (US$ Bn) by Age Group, 2022-2032
Figure 5: Global Attenuated Vaccines Market Value (US$ Bn) by End User, 2022-2032
Figure 6: Global Attenuated Vaccines Market Value (US$ Bn) by Region, 2022-2032
Figure 7: Global Attenuated Vaccines Market Value (US$ Bn) Analysis by Region, 2017-2032
Figure 8: Global Attenuated Vaccines Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 9: Global Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 10: Global Attenuated Vaccines Market Value (US$ Bn) Analysis by Vaccine Type, 2017-2032
Figure 11: Global Attenuated Vaccines Market Value Share (%) and BPS Analysis by Vaccine Type, 2022-2032
Figure 12: Global Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Vaccine Type, 2022-2032
Figure 13: Global Attenuated Vaccines Market Value (US$ Bn) Analysis by Indication, 2017-2032
Figure 14: Global Attenuated Vaccines Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 15: Global Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 16: Global Attenuated Vaccines Market Value (US$ Bn) Analysis by Route of Administration, 2017-2032
Figure 17: Global Attenuated Vaccines Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032
Figure 18: Global Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032
Figure 19: Global Attenuated Vaccines Market Value (US$ Bn) Analysis by Age Group, 2017-2032
Figure 20: Global Attenuated Vaccines Market Value Share (%) and BPS Analysis by Age Group, 2022-2032
Figure 21: Global Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Age Group, 2022-2032
Figure 22: Global Attenuated Vaccines Market Value (US$ Bn) Analysis by End User, 2017-2032
Figure 23: Global Attenuated Vaccines Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 24: Global Attenuated Vaccines Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 25: Global Attenuated Vaccines Market Attractiveness by Vaccine Type, 2022-2032
Figure 26: Global Attenuated Vaccines Market Attractiveness by Indication, 2022-2032
Figure 27: Global Attenuated Vaccines Market Attractiveness by Route of Administration, 2022-2032
Figure 28: Global Attenuated Vaccines Market Attractiveness by Age Group, 2022-2032
Figure 29: Global Attenuated Vaccines Market Attractiveness by End User, 2022-2032
Figure 30: Global Attenuated Vaccines Market Attractiveness by Region, 2022-2032
Figure 31: North America Attenuated Vaccines Market Value (US$ Bn) by Vaccine Type, 2022-2032
Figure 32: North America Attenuated Vaccines Market Value (US$ Bn) by Indication, 2022-2032
Figure 33: North America Attenuated Vaccines Market Value (US$ Bn) by Route of Administration, 2022-2032
Figure 34: North America Attenuated Vaccines Market Value (US$ Bn) by Age Group, 2022-2032
Figure 35: North America Attenuated Vaccines Market Value (US$ Bn) by End User, 2022-2032
Figure 36: North America Attenuated Vaccines Market Value (US$ Bn) by Country, 2022-2032
Figure 37: North America Attenuated Vaccines Market Value (US$ Bn) Analysis by Country, 2017-2032
Figure 38: North America Attenuated Vaccines Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 39: North America Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 40: North America Attenuated Vaccines Market Value (US$ Bn) Analysis by Vaccine Type, 2017-2032
Figure 41: North America Attenuated Vaccines Market Value Share (%) and BPS Analysis by Vaccine Type, 2022-2032
Figure 42: North America Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Vaccine Type, 2022-2032
Figure 43: North America Attenuated Vaccines Market Value (US$ Bn) Analysis by Indication, 2017-2032
Figure 44: North America Attenuated Vaccines Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 45: North America Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 46: North America Attenuated Vaccines Market Value (US$ Bn) Analysis by Route of Administration, 2017-2032
Figure 47: North America Attenuated Vaccines Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032
Figure 48: North America Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032
Figure 49: North America Attenuated Vaccines Market Value (US$ Bn) Analysis by Age Group, 2017-2032
Figure 50: North America Attenuated Vaccines Market Value Share (%) and BPS Analysis by Age Group, 2022-2032
Figure 51: North America Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Age Group, 2022-2032
Figure 52: North America Attenuated Vaccines Market Value (US$ Bn) Analysis by End User, 2017-2032
Figure 53: North America Attenuated Vaccines Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 54: North America Attenuated Vaccines Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 55: North America Attenuated Vaccines Market Attractiveness by Vaccine Type, 2022-2032
Figure 56: North America Attenuated Vaccines Market Attractiveness by Indication, 2022-2032
Figure 57: North America Attenuated Vaccines Market Attractiveness by Route of Administration, 2022-2032
Figure 58: North America Attenuated Vaccines Market Attractiveness by Age Group, 2022-2032
Figure 59: North America Attenuated Vaccines Market Attractiveness by End User, 2022-2032
Figure 60: North America Attenuated Vaccines Market Attractiveness by Country, 2022-2032
Figure 61: Latin America Attenuated Vaccines Market Value (US$ Bn) by Vaccine Type, 2022-2032
Figure 62: Latin America Attenuated Vaccines Market Value (US$ Bn) by Indication, 2022-2032
Figure 63: Latin America Attenuated Vaccines Market Value (US$ Bn) by Route of Administration, 2022-2032
Figure 64: Latin America Attenuated Vaccines Market Value (US$ Bn) by Age Group, 2022-2032
Figure 65: Latin America Attenuated Vaccines Market Value (US$ Bn) by End User, 2022-2032
Figure 66: Latin America Attenuated Vaccines Market Value (US$ Bn) by Country, 2022-2032
Figure 67: Latin America Attenuated Vaccines Market Value (US$ Bn) Analysis by Country, 2017-2032
Figure 68: Latin America Attenuated Vaccines Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 69: Latin America Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 70: Latin America Attenuated Vaccines Market Value (US$ Bn) Analysis by Vaccine Type, 2017-2032
Figure 71: Latin America Attenuated Vaccines Market Value Share (%) and BPS Analysis by Vaccine Type, 2022-2032
Figure 72: Latin America Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Vaccine Type, 2022-2032
Figure 73: Latin America Attenuated Vaccines Market Value (US$ Bn) Analysis by Indication, 2017-2032
Figure 74: Latin America Attenuated Vaccines Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 75: Latin America Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 76: Latin America Attenuated Vaccines Market Value (US$ Bn) Analysis by Route of Administration, 2017-2032
Figure 77: Latin America Attenuated Vaccines Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032
Figure 78: Latin America Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032
Figure 79: Latin America Attenuated Vaccines Market Value (US$ Bn) Analysis by Age Group, 2017-2032
Figure 80: Latin America Attenuated Vaccines Market Value Share (%) and BPS Analysis by Age Group, 2022-2032
Figure 81: Latin America Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Age Group, 2022-2032
Figure 82: Latin America Attenuated Vaccines Market Value (US$ Bn) Analysis by End User, 2017-2032
Figure 83: Latin America Attenuated Vaccines Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 84: Latin America Attenuated Vaccines Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 85: Latin America Attenuated Vaccines Market Attractiveness by Vaccine Type, 2022-2032
Figure 86: Latin America Attenuated Vaccines Market Attractiveness by Indication, 2022-2032
Figure 87: Latin America Attenuated Vaccines Market Attractiveness by Route of Administration, 2022-2032
Figure 88: Latin America Attenuated Vaccines Market Attractiveness by Age Group, 2022-2032
Figure 89: Latin America Attenuated Vaccines Market Attractiveness by End User, 2022-2032
Figure 90: Latin America Attenuated Vaccines Market Attractiveness by Country, 2022-2032
Figure 91: Europe Attenuated Vaccines Market Value (US$ Bn) by Vaccine Type, 2022-2032
Figure 92: Europe Attenuated Vaccines Market Value (US$ Bn) by Indication, 2022-2032
Figure 93: Europe Attenuated Vaccines Market Value (US$ Bn) by Route of Administration, 2022-2032
Figure 94: Europe Attenuated Vaccines Market Value (US$ Bn) by Age Group, 2022-2032
Figure 95: Europe Attenuated Vaccines Market Value (US$ Bn) by End User, 2022-2032
Figure 96: Europe Attenuated Vaccines Market Value (US$ Bn) by Country, 2022-2032
Figure 97: Europe Attenuated Vaccines Market Value (US$ Bn) Analysis by Country, 2017-2032
Figure 98: Europe Attenuated Vaccines Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 99: Europe Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 100: Europe Attenuated Vaccines Market Value (US$ Bn) Analysis by Vaccine Type, 2017-2032
Figure 101: Europe Attenuated Vaccines Market Value Share (%) and BPS Analysis by Vaccine Type, 2022-2032
Figure 102: Europe Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Vaccine Type, 2022-2032
Figure 103: Europe Attenuated Vaccines Market Value (US$ Bn) Analysis by Indication, 2017-2032
Figure 104: Europe Attenuated Vaccines Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 105: Europe Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 106: Europe Attenuated Vaccines Market Value (US$ Bn) Analysis by Route of Administration, 2017-2032
Figure 107: Europe Attenuated Vaccines Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032
Figure 108: Europe Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032
Figure 109: Europe Attenuated Vaccines Market Value (US$ Bn) Analysis by Age Group, 2017-2032
Figure 110: Europe Attenuated Vaccines Market Value Share (%) and BPS Analysis by Age Group, 2022-2032
Figure 111: Europe Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Age Group, 2022-2032
Figure 112: Europe Attenuated Vaccines Market Value (US$ Bn) Analysis by End User, 2017-2032
Figure 113: Europe Attenuated Vaccines Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 114: Europe Attenuated Vaccines Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 115: Europe Attenuated Vaccines Market Attractiveness by Vaccine Type, 2022-2032
Figure 116: Europe Attenuated Vaccines Market Attractiveness by Indication, 2022-2032
Figure 117: Europe Attenuated Vaccines Market Attractiveness by Route of Administration, 2022-2032
Figure 118: Europe Attenuated Vaccines Market Attractiveness by Age Group, 2022-2032
Figure 119: Europe Attenuated Vaccines Market Attractiveness by End User, 2022-2032
Figure 120: Europe Attenuated Vaccines Market Attractiveness by Country, 2022-2032
Figure 121: East Asia Attenuated Vaccines Market Value (US$ Bn) by Vaccine Type, 2022-2032
Figure 122: East Asia Attenuated Vaccines Market Value (US$ Bn) by Indication, 2022-2032
Figure 123: East Asia Attenuated Vaccines Market Value (US$ Bn) by Route of Administration, 2022-2032
Figure 124: East Asia Attenuated Vaccines Market Value (US$ Bn) by Age Group, 2022-2032
Figure 125: East Asia Attenuated Vaccines Market Value (US$ Bn) by End User, 2022-2032
Figure 126: East Asia Attenuated Vaccines Market Value (US$ Bn) by Country, 2022-2032
Figure 127: East Asia Attenuated Vaccines Market Value (US$ Bn) Analysis by Country, 2017-2032
Figure 128: East Asia Attenuated Vaccines Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 129: East Asia Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 130: East Asia Attenuated Vaccines Market Value (US$ Bn) Analysis by Vaccine Type, 2017-2032
Figure 131: East Asia Attenuated Vaccines Market Value Share (%) and BPS Analysis by Vaccine Type, 2022-2032
Figure 132: East Asia Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Vaccine Type, 2022-2032
Figure 133: East Asia Attenuated Vaccines Market Value (US$ Bn) Analysis by Indication, 2017-2032
Figure 134: East Asia Attenuated Vaccines Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 135: East Asia Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 136: East Asia Attenuated Vaccines Market Value (US$ Bn) Analysis by Route of Administration, 2017-2032
Figure 137: East Asia Attenuated Vaccines Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032
Figure 138: East Asia Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032
Figure 139: East Asia Attenuated Vaccines Market Value (US$ Bn) Analysis by Age Group, 2017-2032
Figure 140: East Asia Attenuated Vaccines Market Value Share (%) and BPS Analysis by Age Group, 2022-2032
Figure 141: East Asia Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Age Group, 2022-2032
Figure 142: East Asia Attenuated Vaccines Market Value (US$ Bn) Analysis by End User, 2017-2032
Figure 143: East Asia Attenuated Vaccines Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 144: East Asia Attenuated Vaccines Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 145: East Asia Attenuated Vaccines Market Attractiveness by Vaccine Type, 2022-2032
Figure 146: East Asia Attenuated Vaccines Market Attractiveness by Indication, 2022-2032
Figure 147: East Asia Attenuated Vaccines Market Attractiveness by Route of Administration, 2022-2032
Figure 148: East Asia Attenuated Vaccines Market Attractiveness by Age Group, 2022-2032
Figure 149: East Asia Attenuated Vaccines Market Attractiveness by End User, 2022-2032
Figure 150: East Asia Attenuated Vaccines Market Attractiveness by Country, 2022-2032
Figure 151: South Asia Attenuated Vaccines Market Value (US$ Bn) by Vaccine Type, 2022-2032
Figure 152: South Asia Attenuated Vaccines Market Value (US$ Bn) by Indication, 2022-2032
Figure 153: South Asia Attenuated Vaccines Market Value (US$ Bn) by Route of Administration, 2022-2032
Figure 154: South Asia Attenuated Vaccines Market Value (US$ Bn) by Age Group, 2022-2032
Figure 155: South Asia Attenuated Vaccines Market Value (US$ Bn) by End User, 2022-2032
Figure 156: South Asia Attenuated Vaccines Market Value (US$ Bn) by Country, 2022-2032
Figure 157: South Asia Attenuated Vaccines Market Value (US$ Bn) Analysis by Country, 2017-2032
Figure 158: South Asia Attenuated Vaccines Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 159: South Asia Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 160: South Asia Attenuated Vaccines Market Value (US$ Bn) Analysis by Vaccine Type, 2017-2032
Figure 161: South Asia Attenuated Vaccines Market Value Share (%) and BPS Analysis by Vaccine Type, 2022-2032
Figure 162: South Asia Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Vaccine Type, 2022-2032
Figure 163: South Asia Attenuated Vaccines Market Value (US$ Bn) Analysis by Indication, 2017-2032
Figure 164: South Asia Attenuated Vaccines Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 165: South Asia Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 166: South Asia Attenuated Vaccines Market Value (US$ Bn) Analysis by Route of Administration, 2017-2032
Figure 167: South Asia Attenuated Vaccines Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032
Figure 168: South Asia Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032
Figure 169: South Asia Attenuated Vaccines Market Value (US$ Bn) Analysis by Age Group, 2017-2032
Figure 170: South Asia Attenuated Vaccines Market Value Share (%) and BPS Analysis by Age Group, 2022-2032
Figure 171: South Asia Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Age Group, 2022-2032
Figure 172: South Asia Attenuated Vaccines Market Value (US$ Bn) Analysis by End User, 2017-2032
Figure 173: South Asia Attenuated Vaccines Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 174: South Asia Attenuated Vaccines Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 175: South Asia Attenuated Vaccines Market Attractiveness by Vaccine Type, 2022-2032
Figure 176: South Asia Attenuated Vaccines Market Attractiveness by Indication, 2022-2032
Figure 177: South Asia Attenuated Vaccines Market Attractiveness by Route of Administration, 2022-2032
Figure 178: South Asia Attenuated Vaccines Market Attractiveness by Age Group, 2022-2032
Figure 179: South Asia Attenuated Vaccines Market Attractiveness by End User, 2022-2032
Figure 180: South Asia Attenuated Vaccines Market Attractiveness by Country, 2022-2032
Figure 181: Oceania Attenuated Vaccines Market Value (US$ Bn) by Vaccine Type, 2022-2032
Figure 182: Oceania Attenuated Vaccines Market Value (US$ Bn) by Indication, 2022-2032
Figure 183: Oceania Attenuated Vaccines Market Value (US$ Bn) by Route of Administration, 2022-2032
Figure 184: Oceania Attenuated Vaccines Market Value (US$ Bn) by Age Group, 2022-2032
Figure 185: Oceania Attenuated Vaccines Market Value (US$ Bn) by End User, 2022-2032
Figure 186: Oceania Attenuated Vaccines Market Value (US$ Bn) by Country, 2022-2032
Figure 187: Oceania Attenuated Vaccines Market Value (US$ Bn) Analysis by Country, 2017-2032
Figure 188: Oceania Attenuated Vaccines Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 189: Oceania Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 190: Oceania Attenuated Vaccines Market Value (US$ Bn) Analysis by Vaccine Type, 2017-2032
Figure 191: Oceania Attenuated Vaccines Market Value Share (%) and BPS Analysis by Vaccine Type, 2022-2032
Figure 192: Oceania Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Vaccine Type, 2022-2032
Figure 193: Oceania Attenuated Vaccines Market Value (US$ Bn) Analysis by Indication, 2017-2032
Figure 194: Oceania Attenuated Vaccines Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 195: Oceania Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 196: Oceania Attenuated Vaccines Market Value (US$ Bn) Analysis by Route of Administration, 2017-2032
Figure 197: Oceania Attenuated Vaccines Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032
Figure 198: Oceania Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032
Figure 199: Oceania Attenuated Vaccines Market Value (US$ Bn) Analysis by Age Group, 2017-2032
Figure 200: Oceania Attenuated Vaccines Market Value Share (%) and BPS Analysis by Age Group, 2022-2032
Figure 201: Oceania Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Age Group, 2022-2032
Figure 202: Oceania Attenuated Vaccines Market Value (US$ Bn) Analysis by End User, 2017-2032
Figure 203: Oceania Attenuated Vaccines Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 204: Oceania Attenuated Vaccines Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 205: Oceania Attenuated Vaccines Market Attractiveness by Vaccine Type, 2022-2032
Figure 206: Oceania Attenuated Vaccines Market Attractiveness by Indication, 2022-2032
Figure 207: Oceania Attenuated Vaccines Market Attractiveness by Route of Administration, 2022-2032
Figure 208: Oceania Attenuated Vaccines Market Attractiveness by Age Group, 2022-2032
Figure 209: Oceania Attenuated Vaccines Market Attractiveness by End User, 2022-2032
Figure 210: Oceania Attenuated Vaccines Market Attractiveness by Country, 2022-2032
Figure 211: MEA Attenuated Vaccines Market Value (US$ Bn) by Vaccine Type, 2022-2032
Figure 212: MEA Attenuated Vaccines Market Value (US$ Bn) by Indication, 2022-2032
Figure 213: MEA Attenuated Vaccines Market Value (US$ Bn) by Route of Administration, 2022-2032
Figure 214: MEA Attenuated Vaccines Market Value (US$ Bn) by Age Group, 2022-2032
Figure 215: MEA Attenuated Vaccines Market Value (US$ Bn) by End User, 2022-2032
Figure 216: MEA Attenuated Vaccines Market Value (US$ Bn) by Country, 2022-2032
Figure 217: MEA Attenuated Vaccines Market Value (US$ Bn) Analysis by Country, 2017-2032
Figure 218: MEA Attenuated Vaccines Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 219: MEA Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 220: MEA Attenuated Vaccines Market Value (US$ Bn) Analysis by Vaccine Type, 2017-2032
Figure 221: MEA Attenuated Vaccines Market Value Share (%) and BPS Analysis by Vaccine Type, 2022-2032
Figure 222: MEA Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Vaccine Type, 2022-2032
Figure 223: MEA Attenuated Vaccines Market Value (US$ Bn) Analysis by Indication, 2017-2032
Figure 224: MEA Attenuated Vaccines Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 225: MEA Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 226: MEA Attenuated Vaccines Market Value (US$ Bn) Analysis by Route of Administration, 2017-2032
Figure 227: MEA Attenuated Vaccines Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032
Figure 228: MEA Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032
Figure 229: MEA Attenuated Vaccines Market Value (US$ Bn) Analysis by Age Group, 2017-2032
Figure 230: MEA Attenuated Vaccines Market Value Share (%) and BPS Analysis by Age Group, 2022-2032
Figure 231: MEA Attenuated Vaccines Market Y-o-Y Growth (%) Projections by Age Group, 2022-2032
Figure 232: MEA Attenuated Vaccines Market Value (US$ Bn) Analysis by End User, 2017-2032
Figure 233: MEA Attenuated Vaccines Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 234: MEA Attenuated Vaccines Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 235: MEA Attenuated Vaccines Market Attractiveness by Vaccine Type, 2022-2032
Figure 236: MEA Attenuated Vaccines Market Attractiveness by Indication, 2022-2032
Figure 237: MEA Attenuated Vaccines Market Attractiveness by Route of Administration, 2022-2032
Figure 238: MEA Attenuated Vaccines Market Attractiveness by Age Group, 2022-2032
Figure 239: MEA Attenuated Vaccines Market Attractiveness by End User, 2022-2032
Figure 240: MEA Attenuated Vaccines Market Attractiveness by Country, 2022-2032
